This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.
Pharmaceutics, 18(1)
Citation
Zavvar, Taraneh Sadat; Santo, Giulia; Gruber, Leonhard; Kronthaler, Ariane; Hagenbuchner, Judith; Skvortsova, Ira; Piro, Inken; Steiger, Katja; Martinovic, Vladan; Minasch, Danijela; Löffler-Ragg, Judith; di Santo, Gianpaolo; Virgolini, Irene J; von Guggenberg, Elisabeth. (2026). Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.. Pharmaceutics, 18(1). https://doi.org/10.3390/pharmaceutics18010138